3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
27
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Fatigue
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Blood Specimen Collection
7
Drug Therapy
6
Surveys and Questionnaires
5
Radiotherapy
5
Radiosurgery
5
Docetaxel
5
Therapeutics
4
Specimen Handling
4
Immunotherapy
4
Hepatectomy
4
exemestane
3
enzalutamide
3
apalutamide
3
Trastuzumab
3
Hematologic Tests
3
Data Collection
3
Biopsy
3
Biological Assay
3
Anastrozole
3
Abiraterone Acetate
3
trastuzumab deruxtecan
2
palbociclib
2
darolutamide
2
abiraterone
2
abemaciclib
2
Wearable Electronic Devices
2
Triptorelin Pamoate
2
Tamoxifen
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasm Metastasis
×
Zoledronic Acid
×
Clear all
NCT01062503
2015-04-27
SubDueP
University Health Network, Toronto
Completed
48 enrolled